{"filing":{"accession_number":"0001575872-26-000514","cik":"0001135951","ticker":"RDY","company_name":"DR REDDYS LABORATORIES LTD","form":"6-K","filing_date":"2026-07-22","report_date":null,"primary_document":"rdy0923_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1135951/000157587226000514/rdy0923_6k.htm"},"events":[{"id":19363,"run_id":17424,"accession_number":"0001575872-26-000514","anchor_item_number":"EX-99.1","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The disclosure announces approval by the Nomination, Governance and Compensation Committee of a grant of 15,933 stock options to eligible employees under the Dr. Reddy's Employees Stock Option Scheme, 2018, with an exercise price of Rs. 1,206 per share and 100% vesting over 3 years. This is a compensatory arrangement for employees and falls squarely within exec_compensation. The filing is made under SEBI Regulation 30 and includes detailed terms required by the SEBI Master Circular, indicating material disclosure of equity-based compensation.","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-22","form":"6-K","submitted_at":null,"items":[{"id":18435,"accession_number":"0001575872-26-000514","item_number":"EX-99.1","item_title":"rdy0923_ex99-1.htm","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure announces approval by the Nomination, Governance and Compensation Committee of a grant of 15,933 stock options to eligible employees under the Dr. Reddy's Employees Stock Option Scheme, 2018, with an exercise price of Rs. 1,206 per share and 100% vesting over 3 years. This is a compensatory arrangement for employees and falls squarely within exec_compensation. The filing is made under SEBI Regulation 30 and includes detailed terms required by the SEBI Master Circular, indicating material disclosure of equity-based compensation.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-22T12:29:40.494204+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18435,"accession_number":"0001575872-26-000514","item_number":"EX-99.1","item_title":"rdy0923_ex99-1.htm","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure announces approval by the Nomination, Governance and Compensation Committee of a grant of 15,933 stock options to eligible employees under the Dr. Reddy's Employees Stock Option Scheme, 2018, with an exercise price of Rs. 1,206 per share and 100% vesting over 3 years. This is a compensatory arrangement for employees and falls squarely within exec_compensation. The filing is made under SEBI Regulation 30 and includes detailed terms required by the SEBI Master Circular, indicating material disclosure of equity-based compensation.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-22T12:29:40.494204+00:00","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-22"}]}